metricas
covid
Clínica e Investigación en Arteriosclerosis (English Edition) PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol targ...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol target
El tira y afloja de los inhibidores de PCSK9: cumplimiento, efectos adversos y objetivo de colesterol LDL
Francesco Sbrana
Corresponding author
francesco.sbrana@ftgm.it

Corresponding author.
, Beatrice Dal Pino
U.O. Lipoapheresis and Center for Inherited Dyslipidemias, Fondazione Toscana Gabriele Monasterio, Via Moruzzi, 1, 56124 Pisa, Italy
Read
24
Times
was read the article
0
Total PDF
24
Total HTML
Share statistics
Article information
ISSN: 25299123
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 24 0 24

Follow this link to access the full text of the article

Article options
Tools